Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...

FDA convened a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs ...

Indirect funds are essential for supporting the research infrastructure needed to develop innovative solutions to the most ...

Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

The driver of a white Perodua Axia seen circling Bulatan Mahkota in Kluang hundreds of times in a viral video has been ...

A new study shows that the cerebral cortex predicts the future by detecting novel stimuli and forming short-term memory ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

New research provides the first direct evidence that brain lesions causing secondary psychosis map to a common brain circuit ...

Our study investigated the brain circuits involved in psychosis-a condition characterized by delusions, hallucinations, ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...